Development of life-expectancy tables for people with type 2 diabetes

被引:96
|
作者
Leal, Jose [1 ]
Gray, Alastair M. [1 ]
Clarke, Philip M. [2 ]
机构
[1] Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford OX3 7LF, England
[2] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia
基金
英国医学研究理事会;
关键词
Risk factors; Cardiovascular disease; Type; 2; diabetes; Life expectancy; Mathematical modelling and simulation; Education; CARDIOVASCULAR-DISEASE; RANDOMIZED-TRIAL; DECISION-MAKING; HEART-DISEASE; RISK; POPULATION; FRAMINGHAM; SCORE; COMPLICATIONS; COMMUNICATION;
D O I
10.1093/eurheartj/ehn567
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To develop tables that report the life expectancy associated with levels of major modifiable risk factors for patients with type 2 diabetes. A set of tables reporting life-expectancy stratified by age-sex groups for combinations of modifiable risk was constructed based on predictions from the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model. This model is based on a system of parametric proportional hazards risk equations for estimating mortality and vascular complications of diabetes that have been estimated from 3642 patients from the UKPDS. The tables show substantial potential gains in life expectancy within every age group from modifying major risk factors. The estimated life expectancy of men at age of 55 years with type 2 diabetes, 5 years after diagnosis, varies between 13.2 years for a patient who smokes, has systolic blood pressure of 180 mmHg, a total:HDL cholesterol ratio of 8, and HbA(1c) of 10%, and 21.1 years for a non-smoker with SBP of 120 mmHg, total/HDL ratio of 4, and HbA(1c) of 6%. Life expectancy tables provide a potentially useful tool of conveying prognostic information to people with type 2 diabetes and suggest substantial scope for increasing longevity by improving modifiable risk factors.
引用
收藏
页码:834 / 839
页数:6
相关论文
共 50 条
  • [1] Life-expectancy in individuals with type 2 diabetes: Implications for annuities
    Price, Hermione C.
    Cull, Carole A.
    Clarke, Philip M.
    Gray, Alastair M.
    Holman, Rury R.
    [J]. DIABETES, 2007, 56 : A596 - A596
  • [2] Life expectancy continues to be low in people with Type 2 diabetes
    Gholap, N. N.
    Mendis, B.
    Sturrock, N.
    [J]. DIABETIC MEDICINE, 2008, 25
  • [3] Gaps in life expectancy for people with type 1 diabetes
    Lars C. Stene
    [J]. Diabetologia, 2016, 59 : 1150 - 1152
  • [4] Gaps in life expectancy for people with type 1 diabetes
    Stene, Lars C.
    [J]. DIABETOLOGIA, 2016, 59 (06) : 1150 - 1152
  • [5] Retirement and life-expectancy in France
    Bursaux, E
    [J]. M S-MEDECINE SCIENCES, 1996, 12 (05): : 677 - 680
  • [6] Life-expectancy in a nonhomogeneous population
    Wajiga, G
    Adekola, OA
    [J]. JOURNAL OF THE OPERATIONAL RESEARCH SOCIETY, 1998, 49 (09) : 1011 - 1012
  • [7] Impact of type 2 diabetes mellitus on life expectancy in people with heart failure
    Pavlicek, Vojtech
    [J]. DIABETOLOGIE, 2024, 20 (04): : 587 - 588
  • [8] INCREASING LIFE-EXPECTANCY - INTERDISCIPLINARY ASPECTS
    LEHR, U
    [J]. ZEITSCHRIFT FUR GERONTOLOGIE, 1984, 17 (06): : 305 - 305
  • [9] A generalised life-expectancy model for a population
    Adekola, OA
    [J]. JOURNAL OF THE OPERATIONAL RESEARCH SOCIETY, 2002, 53 (08) : 919 - 921
  • [10] WHAT IS THE LIFE-EXPECTANCY FOR DIABETICS IN BULGARIA?
    Mitov, K.
    Petkova, V
    Tachkov, K.
    Kamusheva, M.
    Dimitrova, M.
    Doneva, M.
    Mitkova, Z.
    Manova, M.
    Savova, A.
    Koleva, Y.
    Petrova, G.
    [J]. VALUE IN HEALTH, 2019, 22 : S153 - S153